Takeda Pharmaceutical Co Stock Price History
TAK Stock | USD 13.62 0.05 0.37% |
Below is the normalized historical share price chart for Takeda Pharmaceutical Co extending back to March 06, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Takeda Pharmaceutical stands at 13.62, as last reported on the 30th of November, with the highest price reaching 13.63 and the lowest price hitting 13.57 during the day.
If you're considering investing in Takeda Stock, it is important to understand the factors that can impact its price. Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Takeda Pharmaceutical Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Takeda Pharmaceutical's Variance of 0.7728, coefficient of variation of (841.23), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide.
At this time, Takeda Pharmaceutical's Capital Stock is quite stable compared to the past year. Stock Based Compensation is expected to rise to about 74.4 B this year, although the value of Sale Purchase Of Stock will most likely fall to (2.4 B). . Price To Free Cash Flows Ratio is expected to rise to 36.51 this year, although the value of Price To Sales Ratio will most likely fall to 1.45. Takeda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of October 2008 | 200 Day MA 13.8792 | 50 Day MA 14.026 | Beta 0.464 |
Takeda |
Sharpe Ratio = -0.1158
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TAK |
Estimated Market Risk
0.9 actual daily | 8 92% of assets are more volatile |
Expected Return
-0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Takeda Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Takeda Pharmaceutical by adding Takeda Pharmaceutical to a well-diversified portfolio.
Price Book 0.9443 | Enterprise Value Ebitda 9.0763 | Price Sales 0.0095 | Shares Float 1.6 B | Dividend Share 192 |
Takeda Pharmaceutical Stock Price History Chart
There are several ways to analyze Takeda Stock price data. The simplest method is using a basic Takeda candlestick price chart, which shows Takeda Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 19, 2024 | 14.59 |
Lowest Price | November 20, 2024 | 13.29 |
Takeda Pharmaceutical November 30, 2024 Stock Price Synopsis
Various analyses of Takeda Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Takeda Stock. It can be used to describe the percentage change in the price of Takeda Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Takeda Stock.Takeda Pharmaceutical Accumulation Distribution | 1,643 | |
Takeda Pharmaceutical Price Action Indicator | 0.04 | |
Takeda Pharmaceutical Price Daily Balance Of Power | 0.83 | |
Takeda Pharmaceutical Price Rate Of Daily Change | 1.00 |
Takeda Pharmaceutical November 30, 2024 Stock Price Analysis
Takeda Stock Price History Data
The price series of Takeda Pharmaceutical for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 1.35 with a coefficient of variation of 2.82. The price distribution for the period has arithmetic mean of 14.1. The median price for the last 90 days is 14.24. The company had dividends distributed to its stock-holders on 2024-03-27.Open | High | Low | Close | Volume | ||
11/29/2024 | 13.57 | 13.63 | 13.57 | 13.62 | 373,133 | |
11/27/2024 | 13.49 | 13.63 | 13.49 | 13.57 | 2,240,266 | |
11/26/2024 | 13.42 | 13.47 | 13.38 | 13.44 | 964,824 | |
11/25/2024 | 13.42 | 13.51 | 13.38 | 13.49 | 1,585,831 | |
11/22/2024 | 13.33 | 13.42 | 13.30 | 13.38 | 1,558,137 | |
11/21/2024 | 13.28 | 13.35 | 13.25 | 13.33 | 4,009,399 | |
11/20/2024 | 13.48 | 13.48 | 13.21 | 13.29 | 3,779,099 | |
11/19/2024 | 13.56 | 13.63 | 13.53 | 13.62 | 1,679,462 | |
11/18/2024 | 13.56 | 13.64 | 13.53 | 13.53 | 3,790,693 | |
11/15/2024 | 13.61 | 13.68 | 13.50 | 13.62 | 2,197,155 | |
11/14/2024 | 13.53 | 13.75 | 13.52 | 13.57 | 2,323,406 | |
11/13/2024 | 13.53 | 13.60 | 13.46 | 13.56 | 1,744,324 | |
11/12/2024 | 13.61 | 13.64 | 13.52 | 13.54 | 1,003,699 | |
11/11/2024 | 13.65 | 13.72 | 13.64 | 13.65 | 1,309,086 | |
11/08/2024 | 13.76 | 13.86 | 13.72 | 13.78 | 984,229 | |
11/07/2024 | 13.84 | 13.90 | 13.80 | 13.86 | 1,036,036 | |
11/06/2024 | 13.99 | 13.99 | 13.72 | 13.79 | 1,205,075 | |
11/05/2024 | 14.04 | 14.24 | 14.04 | 14.22 | 905,806 | |
11/04/2024 | 13.95 | 14.11 | 13.94 | 14.05 | 1,538,935 | |
11/01/2024 | 14.00 | 14.07 | 13.94 | 13.96 | 811,765 | |
10/31/2024 | 13.91 | 13.98 | 13.84 | 13.94 | 1,312,153 | |
10/30/2024 | 13.77 | 13.91 | 13.77 | 13.89 | 1,295,956 | |
10/29/2024 | 13.67 | 13.88 | 13.67 | 13.85 | 1,550,576 | |
10/28/2024 | 13.54 | 13.64 | 13.50 | 13.60 | 1,889,392 | |
10/25/2024 | 13.67 | 13.74 | 13.55 | 13.57 | 1,595,012 | |
10/24/2024 | 13.83 | 13.86 | 13.78 | 13.80 | 811,755 | |
10/23/2024 | 13.95 | 13.99 | 13.81 | 13.86 | 1,337,784 | |
10/22/2024 | 14.10 | 14.14 | 14.06 | 14.13 | 978,480 | |
10/21/2024 | 14.29 | 14.32 | 14.14 | 14.15 | 1,089,653 | |
10/18/2024 | 14.24 | 14.36 | 14.20 | 14.33 | 1,179,902 | |
10/17/2024 | 14.10 | 14.26 | 14.09 | 14.26 | 2,029,181 | |
10/16/2024 | 13.99 | 14.09 | 13.98 | 14.08 | 2,003,936 | |
10/15/2024 | 14.17 | 14.22 | 14.03 | 14.05 | 2,893,267 | |
10/14/2024 | 14.15 | 14.35 | 14.15 | 14.34 | 1,044,324 | |
10/11/2024 | 14.12 | 14.31 | 14.11 | 14.30 | 3,156,092 | |
10/10/2024 | 14.29 | 14.32 | 14.23 | 14.31 | 909,292 | |
10/09/2024 | 14.25 | 14.30 | 14.21 | 14.28 | 1,936,584 | |
10/08/2024 | 14.30 | 14.34 | 14.25 | 14.30 | 2,092,685 | |
10/07/2024 | 14.31 | 14.43 | 14.29 | 14.33 | 2,078,612 | |
10/04/2024 | 14.29 | 14.49 | 14.29 | 14.43 | 1,791,777 | |
10/03/2024 | 14.25 | 14.29 | 14.19 | 14.24 | 1,407,728 | |
10/02/2024 | 14.24 | 14.33 | 14.19 | 14.32 | 1,530,078 | |
10/01/2024 | 14.35 | 14.36 | 14.21 | 14.28 | 1,369,646 | |
09/30/2024 | 14.44 | 14.44 | 14.18 | 14.22 | 2,770,759 | |
09/27/2024 | 14.29 | 14.33 | 14.21 | 14.21 | 1,628,905 | |
09/26/2024 | 14.29 | 14.33 | 14.23 | 14.31 | 842,921 | |
09/25/2024 | 14.38 | 14.39 | 14.22 | 14.25 | 5,769,956 | |
09/24/2024 | 14.45 | 14.51 | 14.39 | 14.46 | 2,326,713 | |
09/23/2024 | 14.43 | 14.58 | 14.42 | 14.55 | 1,905,060 | |
09/20/2024 | 14.51 | 14.53 | 14.42 | 14.46 | 1,241,150 | |
09/19/2024 | 14.48 | 14.60 | 14.48 | 14.59 | 1,119,005 | |
09/18/2024 | 14.53 | 14.60 | 14.44 | 14.48 | 1,569,729 | |
09/17/2024 | 14.53 | 14.60 | 14.49 | 14.51 | 1,922,064 | |
09/16/2024 | 14.38 | 14.47 | 14.35 | 14.46 | 1,930,108 | |
09/13/2024 | 14.35 | 14.51 | 14.32 | 14.36 | 2,608,681 | |
09/12/2024 | 14.45 | 14.49 | 14.37 | 14.48 | 779,547 | |
09/11/2024 | 14.40 | 14.49 | 14.35 | 14.48 | 1,012,119 | |
09/10/2024 | 14.51 | 14.55 | 14.47 | 14.55 | 1,027,893 | |
09/09/2024 | 14.49 | 14.60 | 14.49 | 14.54 | 1,103,403 | |
09/06/2024 | 14.55 | 14.57 | 14.45 | 14.47 | 1,480,340 | |
09/05/2024 | 14.64 | 14.65 | 14.52 | 14.58 | 1,577,163 |
About Takeda Pharmaceutical Stock history
Takeda Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Takeda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Takeda Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Takeda Pharmaceutical stock prices may prove useful in developing a viable investing in Takeda Pharmaceutical
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.6 B | 1.3 B | |
Net Income Applicable To Common Shares | 364.6 B | 382.8 B |
Takeda Pharmaceutical Stock Technical Analysis
Takeda Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
Takeda Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Takeda Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Takeda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Takeda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (0.12) | |||
Total Risk Alpha | (0.26) | |||
Treynor Ratio | (11.68) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 192 | Earnings Share 0.59 | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.127 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.